Immunotherapy-focused biotech company LTZ Therapetics Inc. raised $20 million in a series A round that will advance development of its myeloid engager pipeline to treat cancer and autoimmune diseases.
Therapetics is a Tulsa based non-profit that also serves the greater Oklahoma area. We focus on training Mobility and PTSD service dogs for individuals living with disabilities. We train in a variety ...
JPMorgan analyst Hardik Parikh initiated coverage on Viking Therapeutics Inc (NASDAQ:VKTX) with an Overweight rating and a ...
In a report released today, Michael Ulz from Morgan Stanley reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report), with ...
We don't know who maintains this one, or how we heard about it, or even if anyone will pick it back up now that school has started again, but we love the simple idea behind @asusleeps, which is ...
Insys Therapetics, now under criminal investigation for the way it marketed the dangerous drug fentanyl, donated $500,000 to ARDP. ARDP turned to alcohol distributors, the electric utility, and ...
Candid Therapeutics Inc. launched with ex-China control of two bispecific T-cell engager antibodies that it plans to develop for autoimmune diseases. The San Diego-based company will start off with a ...
Therapetics is a Tulsa based non-profit that also serves the greater Oklahoma area. We focus on training Mobility and PTSD service dogs for individuals living with disabilities. We train in a variety ...